• Crestor
• Banned
• Cardiomyopathy
• Cases
• Cholesterol
• Class Action
• Concerns
• Dangers
• Deaths
• Diabetes
• Heart Failure
• Heart Failure Lawsuit
• Heart Failure Lawyer
• Heart Problems
• Kidney Failure
• Kidney Pain
• Lawsuit
• Leg Pain
• Liver Damage
• Liver Failure
• Medication
• Muscle Damage
• Muscle Pain
• News
• Patient Information
• Problem
• Recall
• Renal Failure
• Rhabdomyolysis
• Risk
• Safety
• Side Effects
• Statin Drug
• Warning
• Weight Loss
• Contact a Lawyer

Find a Lawyer in Your State

Need Help?

• Accutane®
• Cerebral Palsy
• Darvocet®
• Denture Cream
• Depuy ASR™ Hip Implant
• Fosamax® Femur Fracture
• MiniMed Insulin Pump
• Multaq®
• Nephrogenic Systemic Fibrosis
• Paxil® Birth Defects
• Propecia®
• Shoulder Pain Pump
• Topamax®
• Truck Accident Lawyer
• Wellbutrin®
• Yaz® Birth Control

Crestor statin drug is a prescription medication that was approved by the FDA in August of 2003 to treat patients with high cholesterol and reduce the risks of heart problems associated with dangerous cholesterol levels. Crestor statin drug is manufactured by AstraZeneca and has been aggressively marketed in the United States since its approval. Crestor statin drug revenues totaled over one billion dollars in the first year of marketing alone.

The Crestor statin drug is one in a group of statins available to lower cholesterol. Crestor statin drug has been touted by it''s manufacturers as a “super statin” that is highly efficient in its purpose. A cohort of the Crestor statin drug, called Baycol, was recalled from the market in August of 2001 because studies found that patients taking this medication were at an increased risk for developing a dangerous degenerative muscle disease called rhabdomyolosis.

Critics of the Crestor statin drug claim that there is sufficient evidence available suggesting similar serious side effects in patients taking Crestor for high cholesterol. When the Crestor statin drug was being evaluated for safety by the FDA prior to its approval, there were concerns about dosage safety. The government found that the Crestor statin drug was not safe at higher doses (80 milligrams) because of the adverse health problems associated with these drug doses. The Crestor statin drug was approved for doses below 40 milligrams with restricted dosing requirements at the 40 mg level.

Since the approval of the Crestor statin drug, reports have established that taking Crestor increases the risk of developing serious adverse health problems. The manufacturers warn people with liver problems that taking the Crestor statin drug can aggravate and worsen liver functioning. They recommend that medical tests be conducted regularly on these patients to test the effects of the Crestor statin drug on liver functions.

The Crestor statin drug may not be appropriate for use in patients who are, or might become pregnant during the course of treatment. The Crestor statin drug has been shown to cause birth defects in clinical trials and is therefore unsafe for pregnant women. The Crestor statin drug may also be unsafe for a woman who is breastfeeding.

Crestor statin drug use may also increase a patient''s chance for developing the muscle condition known as rhabdomyolosis. This condition causes the destruction of muscle cells and can lead to death if not properly diagnosed and treated. The symptoms of this condition include muscle pain, fever, dark urine, nausea, vomiting, and weakness. Severe forms of this condition can lead to kidney failure and other organ damage.

The development of serious adverse health problems has been associated with taking the Crestor statin drug. If you develop any health complications while taking the Crestor statin drug, it is important to seek immediate medical attention. If you have been injured by taking the Crestor statin drug, you may be eligible to seek compensation for your losses. A qualified attorney can advise you of your legal rights and options in a case.

"Possible Crestor®-Heart Failure Link"

Some researchers believe the cholesterol medication Crestor® (rosuvastatin) can increase the severity of heart failure in certain patients.

Coenzyme Q10 (CoQ10), pro...

» Read More

"FDA rejects petition to ban Crestor"

The consumer advocacy group Public Citizen submitted a petition to the FDA a year ago asking the agency to immediately withdraw the anti-cholesterol drug Crestor, but the agency has denied its request.

Crestor belongs to a group of drugs ...

» Read More

"Asians taking Crestor may be at higher risk for rhabdomyolysis"

The FDA has announced that Crestor is being relabeled to add a warning that starter doses should be reduced in Asian-American patients, as well as some other higher risk patients.

A clinical trial found that levels in Asian patients were d...

» Read More